Conflict of Interest and its Significance in Science and Medicine

Science and Engineering Ethics

Volumn 8, Issue 3, 2002, Pages 469-475

  Baldwin, Wendy ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b US Department of Health and Human Services   (United States)

Author keywords

Clinical investigators; Conflict of interest; Disclosure; Objectivity in research; Profit; Transparency

Indexed keywords

BIOMEDICAL AND BEHAVIORAL RESEARCH; CONFERENCE PAPER; CONFLICT OF INTEREST; HUMAN; INDUSTRY; INTERPERSONAL COMMUNICATION; MEDICAL ETHICS; PUBLIC RELATIONS; SCIENCE; STANDARD; UNIVERSITY;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

CONFLICT OF INTEREST; DISCLOSURE; ETHICS, MEDICAL; HUMANS; INDUSTRY; INTERINSTITUTIONAL RELATIONS; SCIENCE; UNIVERSITIES;

EID: 0347303285     PISSN: 13533452     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11948-002-0069-3     Document Type: Article

References (3)

1. Hasselmo, N. (2002) Individual and Institutional Conflict of Interest: Policy Review by Research Universities in the United States, Science and Engineering Ethics 8: 421-427.
2. Hirsch, L.J. (2002) Conflicts of Interest in Drug Development: The Practices of Merck and Co., Inc., Science and Engineering Ethics 8: 429-442.
3. John Paul II (2002) A Message from Pope John Paul II on the occasion of an international conference on the theme: "Conflict of Interest and its Significance in Science and Medicine", held in Warsaw, Poland on 5-6 April, 2002, Science and Engineering Ethics 8: 263-266.